Pages that link to "Q44508304"

The following pages link to Immune reconstitution in severe combined immunodeficiency disease after lectin-treated, T-cell-depleted haplocompatible bone marrow transplantation. (Q44508304):

Displaying 24 items.

• The gene for severe combined immunodeficiency disease in Athabascan-speaking Native Americans is located on chromosome 10p. (Q24538682) (← links)
• Recent advances in treatment of severe primary immunodeficiencies (Q26766170) (← links)
• B-cell reconstitution for SCID: should a conditioning regimen be used in SCID treatment? (Q26828763) (← links)
• B-cell function in severe combined immunodeficiency after stem cell or gene therapy: a review (Q33803725) (← links)
• A trial of alemtuzumab adjunctive therapy in allogeneic hematopoietic cell transplantation with minimal conditioning for severe combined immunodeficiency (Q34052889) (← links)
• Radiosensitive severe combined immunodeficiency disease (Q34095701) (← links)
• Advances in the understanding and treatment of human severe combined immunodeficiency (Q34242655) (← links)
• Hematopoietic stem cell transplantation for primary immunodeficiencies (Q34630754) (← links)
• Genotype, phenotype, and outcomes of nine patients with T-B+NK+ SCID (Q35387846) (← links)
• IL-21 is the primary common γ chain-binding cytokine required for human B-cell differentiation in vivo (Q35917162) (← links)
• Allogeneic hematopoietic cell transplantation for primary immune deficiency diseases: current status and critical needs (Q35975844) (← links)
• Post-transplantation B cell function in different molecular types of SCID (Q36546267) (← links)
• Acute monocytic leukemia in a dog with X-linked severe combined immunodeficiency. (Q36929448) (← links)
• Transplantation of hematopoietic stem cells in human severe combined immunodeficiency: longterm outcomes (Q37233057) (← links)
• Establishing diagnostic criteria for severe combined immunodeficiency disease (SCID), leaky SCID, and Omenn syndrome: the Primary Immune Deficiency Treatment Consortium experience (Q37678465) (← links)
• Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Conso (Q38772827) (← links)
• Transplacental maternal engraftment and posttransplantation graft-versus-host disease in children with severe combined immunodeficiency (Q38904894) (← links)
• Maternal mosaicism for a novel interleukin-2 receptor gamma-chain mutation causing X-linked severe combined immunodeficiency in a Navajo kindred (Q41141113) (← links)
• T cell repertoire development in XSCID dogs following nonconditioned allogeneic bone marrow transplantation (Q41950077) (← links)
• Long term outcomes of severe combined immunodeficiency: therapy implications. (Q45872036) (← links)
• Anti-tetanus toxoid antibody production after mismatched T cell-depleted bone marrow transplantation. (Q46031396) (← links)
• Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency. (Q55334301) (← links)
• Stem cell transplantation for immunodeficiency (Q56941771) (← links)
• Neurologic event-free survival demonstrates a benefit for SCID patients diagnosed by newborn screening (Q89777323) (← links)